MedCap Dirección

Dirección controles de criterios 3/4

El CEO de MedCap's es Anders Dahlberg , nombrado en Nov 2020, tiene una permanencia de 3.42 años. compensación anual total es SEK6.69M, compuesta por 44.3% salario y 55.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.13% de las acciones de la empresa, por valor de SEK8.03M. La antigüedad media del equipo directivo y de la junta directiva es de 3.4 años y 1.9 años, respectivamente.

Información clave

Anders Dahlberg

Chief Executive Officer (CEO)

kr6.7m

Compensación total

Porcentaje del salario del CEO	44.3%
Permanencia del CEO	3.4yrs
Participación del CEO	0.1%
Permanencia media de la dirección	3.4yrs
Promedio de permanencia en la Junta Directiva	1.9yrs

Actualizaciones recientes de la dirección

Recent updates

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Anders Dahlberg en comparación con los beneficios de MedCap?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	kr172m
Sep 30 2023	n/a	n/a	kr150m
Jun 30 2023	n/a	n/a	kr149m
Mar 31 2023	n/a	n/a	kr123m
Dec 31 2022	kr7m	kr3m	kr118m
Sep 30 2022	n/a	n/a	kr118m
Jun 30 2022	n/a	n/a	kr107m
Mar 31 2022	n/a	n/a	kr102m
Dec 31 2021	kr6m	kr3m	kr97m

Compensación vs. Mercado: La compensación total ($USD614.67K) de Anders está en línea con el promedio de empresas de tamaño similar en el mercado Swedish ($USD584.33K).

Compensación vs. Ingresos: La compensación de Anders ha sido consistente con los resultados de la empresa en el último año.

CEO

Anders Dahlberg (47 yo)

3.4yrs

Permanencia

kr6,692,000

Compensación

Mr. Anders Dahlberg serves as the Chief Executive Officer at MedCap AB, since November 1, 2020. Previously he served as Partner of Applied Value AB till August 2017, where he also had been a Chairman. Mr....

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Anders Dahlberg	Chief Executive Officer	3.4yrs	kr6.69m	0.13% SEK 8.5m
Kristina Ekblad	Chief Financial Officer	3.9yrs	sin datos	sin datos
Lars Ångman	Investment Manager	2.3yrs	sin datos	0.034% SEK 2.2m

3.4yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de MCAP se considera experimentado (3.4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Karl Tobieson	Chairman	2.3yrs	kr1.79m	1.23% SEK 79.2m
Torgny Svensson	Member of Scientific Advisory Board	no data	sin datos	sin datos
Lena Söderström	Independent Director	1.9yrs	kr117.00k	sin datos
Karl-Olov Fagerström	Member of Scientific Advisory Board	no data	sin datos	sin datos
Staffan Nilsson	Member of Scientific Advisory Board	no data	sin datos	sin datos
Gunnar Kratz	Member of Scientific Advisory Board	no data	sin datos	sin datos
Holland Cheng	Member of Scientific Advisory Board	no data	sin datos	sin datos
Otto Ankarcrona	Independent Director	1.3yrs	sin datos	sin datos
David Jern	Independent Director	2.3yrs	kr170.00k	sin datos
Malin Enarson	Independent Director	1.3yrs	sin datos	sin datos
Anna Torner	Independent Director	1.9yrs	kr117.00k	sin datos

1.9yrs

Permanencia media

52yo

Promedio de edad

Junta con experiencia: La junta directiva de MCAP no se considera experimentada (1.9 años de permanencia promedio), lo que sugiere una nueva junta directiva.

MedCap Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

MedCap AB (publ), Annual General Meeting, May 06, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Recent updates

MedCap AB (publ), Annual General Meeting, May 06, 2024

MedCap AB (publ) to Report Fiscal Year 2024 Results on Jan 31, 2025

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Full year 2023 earnings released: EPS: kr11.63 (vs kr7.94 in FY 2022)

Investor sentiment improves as stock rises 19%

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

MedCap AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Third quarter 2023 earnings released: EPS: kr2.59 (vs kr2.47 in 3Q 2022)

MedCap AB (publ) to Report First Half, 2024 Results on Jul 19, 2024

Second quarter 2023 earnings released: EPS: kr3.16 (vs kr1.42 in 2Q 2022)

MedCap AB (publ) (OM:MCAP) signed an agreement to acquire SurgiCube International B.V. for €8 million.

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

MedCap AB (publ) to Report Q1, 2024 Results on May 03, 2024

First quarter 2023 earnings released: EPS: kr1.68 (vs kr1.32 in 1Q 2022)

Full year 2022 earnings released: EPS: kr7.94 (vs kr6.52 in FY 2021)

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: kr2.47 (vs kr1.73 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Now 21% undervalued

Now 21% undervalued

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

High number of new and inexperienced directors

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

MedCap AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

High number of new and inexperienced directors

MedCap AB (publ) to Report Q1, 2023 Results on May 03, 2023

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap AB (publ) to Report Q4, 2022 Results on Feb 10, 2023

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Investment Manager recently bought kr828k worth of stock

Third quarter 2021 earnings released: EPS kr1.73 (vs kr0.89 in 3Q 2020)

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Second quarter 2021 earnings released: EPS kr1.06 (vs kr1.33 in 2Q 2020)

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Independent Chairman of the Board recently bought kr1.1m worth of stock

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS kr4.36 (vs kr4.10 in FY 2019)

New 90-day low: kr193

MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

An unknown buyer acquired 10.1% stake in MedCap AB (publ) (OM:MCAP) from Bure Equity AB (publ) (OM:BURE).

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Market bids up stock over the past week

New 90-day high: kr233

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Revenue and earnings miss expectations

Third quarter 2020 earnings released: EPS kr0.89

New 90-day high: kr227

New 90-day high - kr207

MedCap AB (publ) to Report Q2, 2021 Results on Jul 30, 2021

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media